Deleted Tweets From Scott Gottlieb, R-D.C.

Today, #FDA released a final guidance on standards development and the use of standards in regulatory submissions for FDA-regulated biologic products. We recognize the value of standards and encourage their use in the development and control of biologics. https://t.co/PO5HMB7Vtc https://t.co/8gFHSEtVVN

The use of standards, in areas like testing methodology and manufacturing practices, can facilitate product development and reduce the amount of docs needed in a regulatory submission, thus contributing to a more efficient submission evaluation and improving time to market.

RT @FDA_ORA: #DYK that #FDAORA is presenting to @ACILnews on 3/27? FDA ensures that specific sampling, method, & testing info is… https://t.co/La7LGizb46

We’re working collaboratively with sunscreen makers to provide consumers information they need to make the best decisions tailored to needs and preferences. Safe and effective sunscreens are critical to preventing skin cancer and we support new innovations https://t.co/flodL5Um3J

RT @SecAzar: Thanks to the most powerful HIV prevention and treatment tools in history, we have a once-in-a-generation opportuni… https://t.co/PMdXh2Ip68

RT @LimOpinion: Lauren Silvis, chief of staff to @SGottliebFDA tells @ACLAlabs the commissioner is actively talking to members of C… https://t.co/ugxJohV8BM

RT @LimOpinion: @SGottliebFDA @ACLAlabs @US_FDA Silvis says pre-cert-like approach for diagnostics would cut down on number of revi… https://t.co/QYAdyD4LeS

My statement on steps the Agency is taking to prevent potential medical device shortages and ensure safe and effective sterilization amid shutdown of a large contract sterilization facility https://t.co/y70t6x2UPT

RT @FDAOncology: Registration now open for #FDATissueAgnostic19 on April 26, 2019. Join #FDAOncology, @ASCO and Friends… https://t.co/B3UdrA3g3Q

RT @FDAMedia: Statement from FDA Commissioner @SGottliebFDA, on steps the Agency is taking to prevent potential medical device sh… https://t.co/cExP0hGZLU

RT @FDATobacco: Smoking can cause cancer anywhere in the body, including the colon. Colorectal cancer is the second deadliest cance… https://t.co/MRQcMIOQGj

RT @FDATobacco: ICYMI: New FDA and @NIH Population Assessment of Tobacco and Health (PATH) Study restricted-use files are now avail… https://t.co/fGQZ4d5bzA

This is an old database where historical information wasn't easily accessible electronically owing to the system's age. But it's imperative that all safety information be available to the public. We're now prioritizing making ALL of this data available. https://t.co/T1c3qQQQ3E

#FDA approved 15 generics of Cialis (tadalafil) on the earliest lawful approval date for those applications. Typically having three or more generic competitors brings prices down more sharply than with only one or two generic competitors. https://t.co/Oe8mDymUoV

RT @VickyMooreNews: #NEW #FDA advances "landmark" policy changes to modernize #mammography services and improve quality. #breastdensity #m… QT @SGottliebFDA: THREAD: Today, #FDA announced important new steps to modernize breast cancer screening and help empower patients wi… https://t.co/E4KT38PjcN)

#FDA continues efforts to promote drug competition and increase patient access to high-quality, safe, affordable medicines, and has advanced many policies aimed at making it more efficient for companies to bring generic competition to the market.

RT @FrankYiannasFDA: Social media increasingly used as a tool to notify consumers of recalls. Posting recalls on a hard to find bulletin… https://t.co/gZyJNnrmXn

The new proposed rule on mammography will require, for the first time under federal rules, that women receive information about breast density to better inform their healthcare decisions https://t.co/tbNf1tPu3s

Our new proposed rule is a landmark modernization of our approach to overseeing mammography in order to make sure that women continue to receive accurate, actionable information and have access to high quality services https://t.co/hfxBD7KYLs

I appreciate the opportunity to join @npratc to discuss our policy efforts at #FDA to address youth use of tobacco products https://t.co/Xu1FaFxkgK

Today, #FDA released a final guidance on standards development and the use of standards in regulatory submissions for FDA-regulated biologic products. We recognize the value of standards and encourage their use in the development and control of biologics. https://t.co/PO5HMB7Vtc https://t.co/8gFHSEtVVN

The use of standards, in areas like testing methodology and manufacturing practices, can facilitate product development and reduce the amount of docs needed in a regulatory submission, thus contributing to a more efficient submission evaluation and improving time to market.

RT @FDA_ORA: #DYK that #FDAORA is presenting to @ACILnews on 3/27? FDA ensures that specific sampling, method, & testing info is… https://t.co/La7LGizb46

We’re working collaboratively with sunscreen makers to provide consumers information they need to make the best decisions tailored to needs and preferences. Safe and effective sunscreens are critical to preventing skin cancer and we support new innovations https://t.co/flodL5Um3J

RT @SecAzar: Thanks to the most powerful HIV prevention and treatment tools in history, we have a once-in-a-generation opportuni… https://t.co/PMdXh2Ip68

RT @LimOpinion: Lauren Silvis, chief of staff to @SGottliebFDA tells @ACLAlabs the commissioner is actively talking to members of C… https://t.co/ugxJohV8BM

RT @LimOpinion: @SGottliebFDA @ACLAlabs @US_FDA Silvis says pre-cert-like approach for diagnostics would cut down on number of revi… https://t.co/QYAdyD4LeS

My statement on steps the Agency is taking to prevent potential medical device shortages and ensure safe and effective sterilization amid shutdown of a large contract sterilization facility https://t.co/y70t6x2UPT

RT @FDAOncology: Registration now open for #FDATissueAgnostic19 on April 26, 2019. Join #FDAOncology, @ASCO and Friends… https://t.co/B3UdrA3g3Q

RT @FDAMedia: Statement from FDA Commissioner @SGottliebFDA, on steps the Agency is taking to prevent potential medical device sh… https://t.co/cExP0hGZLU

RT @FDATobacco: Smoking can cause cancer anywhere in the body, including the colon. Colorectal cancer is the second deadliest cance… https://t.co/MRQcMIOQGj

RT @FDATobacco: ICYMI: New FDA and @NIH Population Assessment of Tobacco and Health (PATH) Study restricted-use files are now avail… https://t.co/fGQZ4d5bzA

This is an old database where historical information wasn't easily accessible electronically owing to the system's age. But it's imperative that all safety information be available to the public. We're now prioritizing making ALL of this data available. https://t.co/T1c3qQQQ3E

#FDA approved 15 generics of Cialis (tadalafil) on the earliest lawful approval date for those applications. Typically having three or more generic competitors brings prices down more sharply than with only one or two generic competitors. https://t.co/Oe8mDymUoV

RT @VickyMooreNews: #NEW #FDA advances "landmark" policy changes to modernize #mammography services and improve quality. #breastdensity #m… QT @SGottliebFDA: THREAD: Today, #FDA announced important new steps to modernize breast cancer screening and help empower patients wi… https://t.co/E4KT38PjcN)

#FDA continues efforts to promote drug competition and increase patient access to high-quality, safe, affordable medicines, and has advanced many policies aimed at making it more efficient for companies to bring generic competition to the market.

RT @FrankYiannasFDA: Social media increasingly used as a tool to notify consumers of recalls. Posting recalls on a hard to find bulletin… https://t.co/gZyJNnrmXn

The new proposed rule on mammography will require, for the first time under federal rules, that women receive information about breast density to better inform their healthcare decisions https://t.co/tbNf1tPu3s

Our new proposed rule is a landmark modernization of our approach to overseeing mammography in order to make sure that women continue to receive accurate, actionable information and have access to high quality services https://t.co/hfxBD7KYLs

I appreciate the opportunity to join @npratc to discuss our policy efforts at #FDA to address youth use of tobacco products https://t.co/Xu1FaFxkgK